← Eichor
Study identifier: NCT07489456 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Screening for Dysglycemia During Postpartum Period in Women With GDM

Condition: Gestational Diabetes Mellitus (GDM)  ·  Sponsor: University of Sao Paulo General Hospital

PhaseNA
Planned participants182
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

Gestational diabetes mellitus (GDM) is one of the most common clinical conditions in pregnancy, with an increasing incidence due to the rise in overweight women and the postponement of motherhood. It is associated with perinatal complications and an increased risk of developing prediabetes and type 2 diabetes after delivery. Therefore, it is recommended that a 75g oral glucose tolerance test (OGTT-75g) be performed between 6 and 12 weeks postpartum. Despite its relevance, the rate of adherence to the test is low. Recent studies also indicate that measuring blood glucose one hour after the overload may be more sensitive than the traditional two-hour measurement in the early detection of dysglycemia. This study aims to evaluate strategies for qualifying the screening of metabolic changes in the postpartum period among women with GDM. The objectives are: (1) to analyze the impact of sending reminders via WhatsApp on the attendance rate for the 75g OGTT; and (2) to compare the frequency of prediabetes and diabetes diagnoses using two different diagnostic strategies applied to the same test-the traditional (fasting and 2-hour blood glucose) and the alternative (fasting and 1-hour blood glucose).

This description comes directly from the study's public registry record.

Talk to the study team

Tatiana A Zaccara, MD PhD  ·  +551126616209  ·  tatiana.assuncao@hc.fm.usp.br

Always discuss trial participation with your own doctor first.

Locations (1)

University of Sao Paulo General HospitalSão Paulo, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07489456